Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

U.S. Bill Aims To Streamline Combo Product Regulation

This article was originally published in PharmAsia News

Executive Summary

In a move that could affect applicants from Asia and elsewhere, a U.S. Senate bill aims to streamline device/drug combination registrations at the FDA by letting the agency rely on prior premarket approvals and approved drug findings to help support new product approvals, among other reforms.

You may also be interested in...



CMS Proposes DME Rule For Diabetic CGMs, Home-Use Infusion Pumps

More external infusion pumps used in the home and continuous glucose monitors for diabetics would be reimbursed under a proposed Medicare agency rule.

Device Week, 30 October 2020 – Medtech Money Influences US Elections; User-Fee Negotiations Kick Off

In this week’s podcast we discuss which political candidates are getting campaign donations from the medtech industry in the 2020 US Senate and House elections, and where the FDA and other stakeholders – including the medtech industry – stand as device user-fee negotiations get underway.

CMS Sets Insurers’ Deadlines To Comply With Final Health Care Price Transparency Rule

A final Medicare agency rule requiring insurers to reveal coverage prices for device-related procedures and tests will let consumers shop health services.

Topics

UsernamePublicRestriction

Register

ID1132380

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel